DSM Venturing was among the investors in a round that will help the lab-grown meat developer widen its product range.

Netherlands-based cultured meat developer Meatable received $47m in series A financing yesterday from investors including DSM Venturing, the corporate venturing arm of health and nutrition product manufacturer Royal DSM. Section 32, BlueYard Capital, Agronomics, Humboldt and private investors Rick Klausner, Jeffrey Leiden and Taavet Hinrikus also took part in the round. Meatable is working on…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.